You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Pioglitazone HCl-metFORMIN HCl
Pioglitazone HCl-metformin HCl is a combination medication used to improve glycemic control in adults with type 2 diabetes mellitus. This combination leverages the mechanisms of action of both drugs: pioglitazone, a thiazolidinedione, enhances insulin sensitivity, while metformin, a biguanide, reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. Together, they work synergistically to lower blood sugar levels.
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Pioglitazone HCl-metFORMIN HCl ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How long does it take for pioglitazone HCl-metformin HCl to start working?
Patients may start to see improvements in blood glucose levels within a few weeks, but it may take up to three months for the full effect.
Can I stop taking this medication suddenly?
It is not advisable to stop taking pioglitazone HCl-metformin HCl abruptly, as this may lead to poor glycemic control. Consult your healthcare provider before making any changes.
Are there any dietary restrictions while taking this medication?
There are no specific dietary restrictions; however, following a balanced diet and monitoring carbohydrate intake can help manage blood glucose levels effectively.
What should I do if I miss a dose of pioglitazone HCl-metformin HCl?
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double up on doses.
Is pioglitazone HCl-metformin HCl safe for long-term use?
This medication can be used long-term under medical supervision, but regular follow-ups are important to monitor its effectiveness and any potential side effects.
Comprehensive Drug Guide
How Does Pioglitazone HCl-metFORMIN HCl Work?
- Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPAR-γ), which regulates genes involved in glucose and lipid metabolism, leading to improved insulin sensitivity in muscle and adipose tissue.
- Metformin reduces glucose production in the liver and improves insulin sensitivity, which enhances glucose uptake and utilization by peripheral tissues.
Common Dosages
- Tablets: Combination of 15 mg, 30 mg, or 45 mg of pioglitazone with 500 mg or 1000 mg of metformin
Typical Dosing
- The typical starting dose is 15 mg of pioglitazone and 500 mg of metformin, taken once daily. Doses may be adjusted based on patient tolerance and glycemic control, with a maximum dose of 45 mg of pioglitazone and 2000 mg of metformin per day.
Typical Dosing
FDA Approved Indications
- The management of type 2 diabetes mellitus in conjunction with diet and exercise, particularly in patients who are overweight or obese.
Who Shouldn't Take Pioglitazone HCl-metFORMIN HCl?
- Known hypersensitivity to pioglitazone, metformin, or any of the components
- Severe renal impairment (eGFR < 30 mL/min)
- Active bladder cancer (for pioglitazone)
- Diabetic ketoacidosis
Advice From The Pharmacist
- Take this medication with meals to reduce the risk of gastrointestinal side effects associated with metformin.
- Regularly monitor blood glucose levels as directed by your healthcare provider.
- Inform your healthcare provider about all medications you are taking, as there may be interactions that affect blood sugar control.
- Lifestyle modifications, such as diet and exercise, should be continued alongside medication for optimal glycemic control.
Side Effects of Pioglitazone HCl-metFORMIN HCl
Common Side Effects
- Gastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)
- Weight gain (more commonly associated with pioglitazone)
- Edema (swelling due to fluid retention)
Uncommon/Severe Side Effects
- Lactic acidosis (a rare but serious condition associated with metformin, characterized by symptoms like muscle pain, difficulty breathing, and abdominal discomfort)
- Heart failure (associated with pioglitazone use, particularly in patients with a history of heart failure)
Risks and Warnings of Pioglitazone HCl-metFORMIN HCl
- Lactic Acidosis: Metformin can cause lactic acidosis, especially in patients with renal impairment, liver disease, or those undergoing procedures involving contrast agents.
- Cardiovascular Risk: Monitor for signs of heart failure, particularly in patients with risk factors or previous heart failure history.
- Bladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; consider risk factors before prescribing.
Interactions with Pioglitazone HCl-metFORMIN HCl
Common Drug Interactions
- Diuretics: May increase the risk of renal impairment when used with metformin.
- Other Antidiabetic Agents: Combining with other glucose-lowering medications may increase the risk of hypoglycemia.
- CYP450 Inhibitors/Inducers: Medications that affect liver enzyme activity may alter the effectiveness of pioglitazone.
Alternatives to Pioglitazone HCl-metFORMIN HCl
- Metformin alone: Often the first-line treatment for type 2 diabetes, especially in overweight patients.
- Sulfonylureas: Such as glipizide or glyburide, which stimulate insulin secretion from the pancreas.
- Other combinations: Such as DPP-4 inhibitors or SGLT2 inhibitors, which may be considered based on individual patient needs and comorbidities.
